Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-27 08:07 am Sale | 2026-03-31 | 13G | GRACE THERAPEUTICS, INC GRCE | Orin Hirschman | 814,000 4.900% | -93,217 (-10.28%) | Filing History |
| 2026-02-17 6:17 pm Purchase | 2025-12-31 | 13G | GRACE THERAPEUTICS, INC GRCE | ADAR1 Capital Management LLC | 1,648,791 9.900% | 114,537 (+7.47%) | Filing History |
| 2026-02-13 5:00 pm Purchase | 2025-12-31 | 13G | GRACE THERAPEUTICS, INC GRCE | Nantahala Capital Management, LLC | 1,586,659 9.990% | 182,627 (+13.01%) | Filing History |
| 2026-01-28 2:24 pm Sale | 2025-12-31 | 13G | GRACE THERAPEUTICS, INC GRCE | Orin Hirschman | 907,217 5.900% | -415,162 (-31.40%) | Filing History |
| 2025-11-14 7:44 pm Purchase | 2025-09-30 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 1,534,254 9.900% | 32,111 (+2.14%) | Filing History |
| 2025-08-14 4:43 pm Purchase | 2025-06-30 | 13G | GRACE THERAPEUTICS, INC GRCE | Nantahala Capital Management, LLC | 1,404,032 9.990% | 12,259 (+0.88%) | Filing History |
| 2025-05-15 7:33 pm Purchase | 2025-03-31 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 1,502,143 9.990% | 472,146 (+45.84%) | Filing History |
| 2025-05-15 4:46 pm Purchase | 2025-03-31 | 13G | GRACE THERAPEUTICS, INC GRCE | Nantahala Capital Management, LLC | 1,391,773 9.990% | 1,391,773 (New Position) | Filing History |
| 2025-05-08 07:51 am Purchase | 2025-03-31 | 13G | GRACE THERAPEUTICS, INC GRCE | Orin Hirschman | 1,322,379 9.900% | 801,296 (+153.78%) | Filing History |
| 2025-01-29 06:13 am Sale | 2024-12-31 | 13G | GRACE THERAPEUTICS, INC GRCE | Orin Hirschman | 521,083 5.100% | -46,729 (-8.23%) | Filing History |
| 2024-11-14 4:40 pm Purchase | 2024-09-30 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 1,029,997 9.990% | 70,426 (+7.34%) | Filing History |
| 2024-11-14 11:58 am Unchanged | 2024-09-30 | 13G | ACASTI PHARMA INC NO PAR ACST | BANK OF AMERICA CORP BAC | 494,698 4.900% | 0 (Unchanged) | Filing History |
| 2024-07-10 9:10 pm Purchase | 2024-06-28 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 959,571 10.200% | 959,571 (New Position) | Filing History |
| 2024-04-09 08:46 am Purchase | 2024-03-27 | 13G | ACASTI PHARMA INC NO PAR ACST | Orin Hirschman | 567,812 6.000% | 567,812 (New Position) | Filing History |
| 2024-02-13 7:03 pm Purchase | 2023-12-31 | 13G | ACASTI PHARMA INC NO PAR ACST | BANK OF AMERICA CORP BAC | 494,698 5.300% | 494,698 (New Position) | Filing History |